The Association between Vitamin D Levels and Thrombus Burden in Patients with ST-Elevation Myocardial Infarction

Faysal Şaylık1, Murat Selçuk2, Tayyar Akbulut1

  • 1Van Training and Research Hospital, Health Sciences University, Van, Turkey.

Insights

Low vitamin D levels are linked to high thrombus burden in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). Vitamin D deficiency independently predicts this condition, impacting treatment outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • Predicting high thrombus burden (HTB) before primary percutaneous coronary intervention (PCI) is critical for managing ST-elevation myocardial infarction (STEMI).
  • The role of vitamin D levels as a potential predictor of HTB in STEMI patients requires further investigation.

Purpose of the Study:

  • To investigate the association between vitamin D levels and high thrombus burden (HTB) in patients with ST-elevation myocardial infarction (STEMI) undergoing primary PCI.
  • To determine if vitamin D levels can serve as an independent predictor of HTB in this patient population.

Main Methods:

  • A prospective, observational study involving 257 STEMI patients undergoing primary PCI.
  • Patients were categorized into high thrombus burden (HTB) and low thrombus burden (LTB) groups based on thrombus burden grade.
  • Demographic, laboratory, and angiographic features, including vitamin D levels, were compared between the groups.

Main Results:

  • Patients with HTB exhibited significantly lower vitamin D levels (8.0 ng/mL) compared to those with LTB (17.9 ng/mL).
  • Low vitamin D levels were associated with poorer post-PCI outcomes, including reduced TIMI flow, TIMI myocardial perfusion grade, and ST resolution.
  • Multivariable analysis identified vitamin D as an independent predictor of HTB (OR: 0.76, 95% CI: 0.70-0.82; P<0.001).

Conclusions:

  • Vitamin D levels are an independent predictor of high thrombus burden in STEMI patients treated with primary PCI.
  • A vitamin D level >17.6 ng/mL was identified as an optimal threshold for predicting HTB, with high sensitivity and specificity.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
24
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
56
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
23